Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.

MLA

Shehaj, Ina, et al. “Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.” Cancers, vol. 16, no. 7, Apr. 2024, p. 1371. EBSCOhost, https://doi.org/10.3390/cancers16071371.

APA

Shehaj, I., Schröder, M., Linz, V. C., Krajnak, S., Almstedt, K., Stewen, K., Schwab, R., Hasenburg, A., Schmidt, M., & Heimes, A.-S. (2024). Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers, 16(7), 1371. https://doi.org/10.3390/cancers16071371

Chicago

Shehaj, Ina, Maria Schröder, Valerie Catherine Linz, Slavomir Krajnak, Katrin Almstedt, Kathrin Stewen, Roxana Schwab, Annette Hasenburg, Marcus Schmidt, and Anne-Sophie Heimes. 2024. “Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers.” Cancers 16 (7): 1371. doi:10.3390/cancers16071371.